SCHEMBL1393862

SCHEMBL1393862

C#CC(C)OS(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 4/20 0.42
CA2 P00918 4/20 0.39
CA1 P00915 3/20 0.39
CA12 O43570 3/20 0.39
CA9 Q16790 3/20 0.39
CA3 P07451 1/20 0.39
CA6 P23280 1/20 0.39
CA5A P35218 1/20 0.39
CA7 P43166 1/20 0.39
CA5B Q9Y2D0 1/20 0.39
LMNA P02545 2/20 0.39
VDR P11473 1/20 0.39
TLR9 Q9NR96 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.37
GBA1 P04062 1/20 0.37
KEAP1 Q14145 1/20 0.36
NFE2L2 Q16236 1/20 0.36
ALDH1A1 P00352 4/20 0.36
MMP1 P03956 1/20 0.36
MMP2 P08253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25277145 1.00 GAA (0.42) GAACA2CA1CA12CA9
SCHEMBL8309170 1.00 GAA (0.42) GAACA2CA1CA12CA9
SCHEMBL17264974 0.85 GAA (0.45) GAACA2CA1CA12CA9
SCHEMBL10403709 0.84 GAA (0.43) GAACA2CA1CA12CA9
SCHEMBL8757475 0.84 TDP1 (0.37) CA2CA1CA12CA9CA3
SCHEMBL1629443 0.82 ALDH1A1 (0.42) GAACA2CA1CA12CA9
SCHEMBL10404146 0.82 GAA (0.42) GAACA2CA1CA12CA9
SCHEMBL7457480 0.81 GAA (0.41) GAACA2CA1CA12CA9
SCHEMBL16648913 0.81 GAA (0.41) GAACA2CA1CA12CA9
SCHEMBL7463761 0.81 ALDH1A1 (0.41) GAACA2CA1CA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112794958-B Antibacterial polycarboxylate superplasticizer and preparation method thereof 江苏奥莱特新材料股份有限公司 2022-07-26 CN claimed
CN-112794958-A Antibacterial polycarboxylate superplasticizer and preparation method thereof 江苏奥莱特新材料股份有限公司 2021-05-14 CN claimed
WO-2025264724-A1 MPRO INHIBITORS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-12-26 WO disclosed
US-20250171459-A1 2-METHYL-4',5'-DIHYDROSPIRO[PIPERIDINE-4,7'-THIENO[2,3-C]PYRAN] DERIVATIVES AS INHIBITORS OF APOL1 AND METHODS OF USING SAME VERTEX PHARMA (US) 2025-05-29 US disclosed
CN-119343353-A 2-Methyl-4 ',5' -dihydrospiro [ piperidine-4, 7' -thieno [2,3-c ] pyran ] derivatives as APOL1 inhibitors and methods of use thereof 弗特克斯药品有限公司 2025-01-21 CN disclosed
US-20250011335-A1 SUBSTITUTED PYRIDINES, PYRIDAZINES, PYRIMIDINES, AND 1,2,4-TRIAZINES AS TYK2 INHIBITORS SUDO BIOSCIENCES LIMITED (GB) 2025-01-09 US disclosed
EP-4476227-A1 2-METHYL-4',5'-DIHYDROSPIRO[PIPERIDINE-4,7'-THIENO[2,3-C]PYRAN] DERIVATIVES AS INHIBITORS OF APOL1 AND METHODS OF USING SAME Vertex Pharmaceuticals Incorporated (US) 2024-12-18 EP disclosed
EP-4448523-A1 MACROCYCLIC BTK INHIBITORS Crossfire Oncology Holding B.V. (NL) 2024-10-23 EP disclosed
US-12122785-B2 Substituted pyridines, pyridazines, pyrimidines, and 1,2,4-triazines as TYK2 inhibitors SUDO BIOSCIENCES LIMITED (GB) 2024-10-22 US disclosed
WO-2024138206-A1 FLUOROPYRIDOPYRIMIDINE AND FLUOROQUINAZOLINE DERIVATIES AND METHODS OF USE THEREOF FRONTIER MEDICINES CORPORATION (US) 2024-06-27 WO disclosed
EP-4294807-A1 TYK2 INHIBITORS AND USES THEREOF Sudo Biosciences Limited (GB) 2023-12-27 EP disclosed
US-5391807-A Methods of preparing fluorobenzene derivatives and related compounds SAGAMI CHEMICAL RESEARCH CENTER (JP) 1995-02-21 US disclosed
EP-0636021-A1 PSYCHOACTIVE PROPARGYLAMINE DERIVATIVES UNIVERSITE DE MONTREAL (CA) 1995-02-01 EP disclosed
US-5344953-A Fluorobenzene derivatives SAGAMI CHEMICAL RESEARCH CENTER (JP) 1994-09-06 US disclosed
US-5281742-A Bis(fluorophenyl) carbonate derivatives SAGAMI CHEMICAL RESEARCH CENTER (JP) 1994-01-25 US disclosed
WO-1993020804-A1 PSYCHOACTIVE PROPARGYLAMINE DERIVATIVES UNIVERSITE DE MONTREAL (CA) 1993-10-28 WO disclosed
US-5247082-A 6-imino-7-fluoro-1,4-benzoxazin-3-ones, herbicide intermediate SUMITOMO CHEMICAL COMPANY LIMITED (JP) 1993-09-21 US disclosed
EP-0535613-A1 Imine compounds and their production SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1993-04-07 EP disclosed
EP-0496347-A2 Methods of preparing fluorobenzene derivatives and related compounds SAGAMI CHEMICAL RESEARCH CENTER (JP) 1992-07-29 EP disclosed
US-4275079-A Fungicidal N-alkynylanilides HOFFMANN-LA ROCHE INC. (US) 1981-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12122785-B2 Substituted pyridines, pyridazines, pyrimidines, and 1,2,4-triazines as TYK2 inhibitors TYK2, JAK1, PDXK GAA 2517/4885CA2 3870/4885CA1 4873/4885
US-20250011335-A1 SUBSTITUTED PYRIDINES, PYRIDAZINES, PYRIMIDINES, AND 1,2,4-TRIAZINES AS TYK2 INHIBITORS TYK2, PDXK, JAK1 GAA 2511/4885CA2 4160/4885CA1 4874/4885
US-20250171459-A1 2-METHYL-4',5'-DIHYDROSPIRO[PIPERIDINE-4,7'-THIENO[2,3-C]PYRAN] DERIVATIVES AS INHIBITORS OF APOL1 AND METHODS OF USING SAME APOL1, PDXK, PNLIP GAA 3683/4885CA2 4868/4885CA1 4883/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.